Galanin receptor 2 utilizes distinct signaling pathways to suppress cell proliferation and induce apoptosis in HNSCC
Takeharu Kanazawa1, Kiyoshi Misawa2, Yuki Misawa2
1Department of Otolaryngology‑Head and Neck Surgery, Jichi Medical University School of Medicine, Shimotsuke, Tochigi 329‑0498, Japan.
Abstract:
Galanin and its receptors, GALR1 and GALR2, are tumor suppressors and represent therapeutic targets in head and neck squamous cell carcinoma (HNSCC). In the present study, it was demonstrated that the re‑expression of GALR1 in GALR1 and GALR2‑negative HNSCC cells suppresses tumor cell proliferation. This is mediated via extracellular‑regulated protein kinase‑1/2 (ERK1/2)‑dependent effects on the cyclin‑dependent kinase inhibitors (CKI) and cyclin D1. In combination with galanin, GALR2 also suppressed proliferation by increasing CKI and decreasing cyclin D1 levels. In contrast to GALR1, overexpression of GALR2 also induced caspase‑3‑dependent apoptosis. It was identified that in GALR2‑transfected cells, galanin induced activation of ERK1/2 and suppressed cell proliferation. Galanin stimulation also decreased the expression of cyclin D1 and induced apoptotic DNA ladder formation in GALR2‑transfected cells. Pretreatment with the ERK1/2‑specific inhibitor U0126 and pertussis toxin prevented the suppression of cyclin D1 expression, however did not affect DNA ladder formation. In conclusion, GALR2 expression in the presence of galanin exerts antitumor effects via cell cycle arrest and apoptotic pathways, and reactivation of these pathways may have therapeutic benefits in HNSCC.
Insights
Galanin receptors GALR1 and GALR2 suppress head and neck squamous cell carcinoma (HNSCC) growth. Reactivating these pathways, particularly GALR2, offers therapeutic potential by halting cell cycle progression and inducing apoptosis.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- Galanin and its receptors, GALR1 and GALR2, function as tumor suppressors.
- These receptors are potential therapeutic targets in head and neck squamous cell carcinoma (HNSCC).
Purpose of the Study:
- To investigate the antitumor effects of GALR1 and GALR2 re-expression in HNSCC.
- To elucidate the molecular mechanisms underlying galanin-mediated tumor suppression.
Main Methods:
- Re-expression of GALR1 and GALR2 in HNSCC cell lines.
- Assessment of cell proliferation, cell cycle regulators (CKI, cyclin D1), and apoptosis (caspase-3).
- Pharmacological inhibition of ERK1/2 signaling pathway (U0126) and G-protein coupled receptors (pertussis toxin).
Main Results:
- GALR1 re-expression suppressed HNSCC cell proliferation via ERK1/2-dependent regulation of CKI and cyclin D1.
- GALR2 re-expression, in combination with galanin, increased CKI, decreased cyclin D1, and induced apoptosis.
- Galanin stimulation in GALR2-expressing cells activated ERK1/2, suppressed proliferation, decreased cyclin D1, and induced DNA ladder formation.
- ERK1/2 inhibition blocked cyclin D1 suppression but not apoptosis induction by galanin in GALR2-expressing cells.
Conclusions:
- GALR2, in the presence of galanin, exerts antitumor effects through cell cycle arrest and apoptosis in HNSCC.
- Reactivation of GALR1 and GALR2 signaling pathways holds therapeutic promise for HNSCC treatment.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes


